BioSig Technologies, Inc. STEX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s financing cash flow?
- BioSig Technologies, Inc. (STEX) reported financing cash flow of -$1.64M in Q1 2026.
- How has BioSig Technologies, Inc.'s financing cash flow changed year-over-year?
- BioSig Technologies, Inc.'s financing cash flow decreased by 134.8% year-over-year, from $4.7M to -$1.64M.
- What is the long-term trend for BioSig Technologies, Inc.'s financing cash flow?
- Over 3 years (2022 to 2025), BioSig Technologies, Inc.'s financing cash flow has grown at a 73.1% compound annual growth rate (CAGR), from $10.57M to $54.88M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.